New psoriasis shot shows promise in Mid-Stage trial
NCT ID NCT06592274
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 27 times
Summary
This study tests a new medicine called HB0017, given as an injection, for people with moderate to severe plaque psoriasis. The goal is to see how well different dosing schedules clear the skin and reduce symptoms. About 200 adults aged 18-75 with chronic psoriasis will participate in this phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS (PSO) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chongqing Traditional Chinese Medicine Hospital
RECRUITINGChongqing, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hangzhou First People's Hospital
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiangsu University Affiliated Hospital
RECRUITINGZhenjiang, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiaxing First Hospital
RECRUITINGJiaxing, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jilin University Second Hospital
RECRUITINGChangchun, Jilin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jining First People's Hospital
RECRUITINGJining, Shandong, 0531, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ningbo Second Hospital
RECRUITINGNingbo, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shandong First Medical University Affiliated Dermatology Hospital
NOT_YET_RECRUITINGJinan, Shandong, 0531, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanxi Medical University Second Hospital
RECRUITINGTaiyuan, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southern Medical University Dermatology Hospital
RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Bengbu Medical College
RECRUITINGBengbu, Anhui, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wenzhou Medical University Affiliated First Hospital
RECRUITINGWenzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wuxi Second People's Hospital
RECRUITINGWuxi, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xingtai People's Hospital
RECRUITINGXingtai, Shandong, 0531, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.